Unlike uterine leiomyomas, which frequently harbor MED12 exon 2 mutations, most IVLs display wild-type MED12 or distinct variants, suggesting a different molecular pathogenesis [28,29,30]. Here, MED12 is linked to uterine corpus leiomyoma.